Starting today, Ava will automatically assess user data to detect a biphasic shift in physiological parameters during a woman’s cycle.
Swiss medtech startup also announces launch of clinical trial studying efficacy of cycle-tracking bracelet in detection of infection during pregnancy |
| [30-January-2018] |
| ZURICH and SAN FRANCISCO, Jan. 30, 2018 /PRNewswire/ -- Ava, a medical technology company best known for its popular fertility-tracking Ava bracelet, announced it has added a new feature that will help provide users with key insights into whether they have ovulated during a monthly cycle. Starting today, Ava will automatically assess user data to detect a biphasic shift in physiological parameters during a woman’s cycle. In a biphasic pattern, some of the physiological parameters including skin temperature and pulse rate increase in response to the increase in progesterone after ovulation. This is important because most women with ovulatory cycles exhibit a biphasic parameters pattern on their charts, and a key factor in getting pregnant is for ovulation to occur. However, up to 12 percent of women actually have anovulatory cycles, i.e., cycles without an ovulation. “Besides wanting to know when the fertile window is, our Ava users typically want to know if they have ovulated at all, and so we believe this new feature meets a critical demand,” said Lea von Bidder, CEO and Co-Founder of Ava, noting that Ava is the only device available today that can detect a bi-phasic pattern not just based on temperature, but also based on other parameters such as pulse rate. “This is a critical difference, as in some cases, the shift in parameters can’t be seen in temperature, but Ava’s algorithm may still recognize it in other parameters related to progesterone.” Ava Launches with Clinical Trial on Detection of Infections During Pregnancy Led by Prof. Brigitte Leeners, the study will monitor 50 women wearing who are hospitalized with PPROM (preterm premature rupture of membranes) for the 24 hours from rupture to infection. Patient participants will be provided with Ava bracelets and researchers will study patterns in the data collected. “Ideally insights from this research will enable us to develop features for Ava that can provide users with a pregnancy monitoring service that screens for complications and thus significantly improves the chance to identify critical infection situations early on,” said Ava Vice President of Research and Development Peter Stein. “We see this as yet another step in the direction of developing technology that can truly improve and possibly even save women’s lives.” About Ava Media Contact: View original content with multimedia:http://www.prnewswire.com/news-releases/ava-unveils-new-feature-that-detects-bi-phasic-shift-in-users-monthly-cycle-to-help-confirm-ovulation-300590016.html SOURCE Ava |
